Latest Breaking News On - Blinded clinical study evaluating - Page 1 : comparemela.com

A novel topical product featuring proprietary PATH-3 Technology could surpass hydroquinone in helping to treat facial dyschromia, according to a new study.

United statesNew yorkLaser skin surgery centerAlastin skincareSkin surgery centerCosmetic laser dermtologyModern dermatologyBlinded clinical study evaluatingNovel topical productJordanv wangFormulation amp scienceSkin care